Springer Healthcare IME
Springer Healthcare Independent Medical Education (IME) creates expert-led educational programs that build upon the latest research and professional practice guidelines. Our suite of educational programs are designed to bring about meaningful change in physician behavior by increasing diagnostic ability, optimizing treatment regimens, and thereby contributing to improved patient outcomes.
Springer Healthcare IME
Advancements in Tumor-Agnostic Cancer Treatment: Expert Panel Discussion
Join leading oncologists Dr. Schneider, Dr. Peters, and Dr. Hendricks in an insightful Q&A session exploring the latest advancements in tumor-agnostic cancer treatment. This comprehensive video covers the integration of new therapies for non-small cell lung cancer (NSCLC), the transformative role of biomarker testing and liquid biopsies, and the global efforts to standardize treatment guidelines and improve access to care.
Key Topics:
• New FDA and EMA approvals for adjuvant and neoadjuvant therapies in early stage NSCLC
• Clinical applications and benefits of biomarker testing and liquid biopsies
• Challenges and strategies for global implementation of standardized lung cancer treatment guidelines
Access a downloadable transcript of this webinar at https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/#qa
This is episode #4 of 4, and is part of an ACCME- and EACCME-accredited, Independent Medical Education program entitled, Biomarker-Positive Disease: A Personalized Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.
To learn more about the full program or to CLAIM YOUR CREDITS, visit https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/
---
This activity is supported by independent educational grants from Roche and Illumina.
Key Topics:
• New FDA and EMA approvals for adjuvant and neoadjuvant therapies in early stage NSCLC
• Clinical applications and benefits of biomarker testing and liquid biopsies
• Challenges and strategies for global implementation of standardized lung cancer treatment guidelines
Access a downloadable transcript of this webinar at https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/#qa
This is episode #4 of 4, and is part of an ACCME- and EACCME-accredited, Independent Medical Education program entitled, Biomarker-Positive Disease: A Personalized Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.
To learn more about the full program or to CLAIM YOUR CREDITS, visit https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/
---
This activity is supported by independent educational grants from Roche and Illumina.
Comments 0
Login to view comments.
Click here to Login
